Results 291 to 300 of about 130,782 (308)

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Lancet, The, 1999
Katherine Samaras, Donald J Chisholm
exaly  

BRAF and MEK Inhibitors

2013
openaire   +1 more source

MEK Inhibitor-Associated Retinopathy (MEKAR)

2021
openaire   +1 more source

Hereditary angioedema with normal C1-inhibitor activity in women

Lancet, The, 2000
Konrad Bork
exaly  

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

Lancet, The, 2017
Marc A Riedl, Avner Reshef, Sladjana Andrejevic   +2 more
exaly  

[BRAF inhibitor and MEK inhibitor].

Gan to kagaku ryoho. Cancer & chemotherapy, 2015
openaire   +1 more source

386 INVITED MEK-RAF Inhibitors

European Journal of Cancer, 2011
openaire   +1 more source

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Nature Reviews Drug Discovery, 2010
exaly  

MEK inhibitor-induced chronic paronychia

Journal of the American Academy of Dermatology, 2019
openaire   +1 more source